Immunotherapy Targeting α-Synuclein, with Relevance for Future Treatment of Parkinson‘s Disease and Other Lewy Body Disorders
-
- Veronica Lindström
- Department of Public Health/Geriatrics, Rudbeck Laboratory, Uppsala University, 751 85Uppsala, Sweden
-
- Elisabet Ihse
- Department of Public Health/Geriatrics, Rudbeck Laboratory, Uppsala University, 751 85Uppsala, Sweden
-
- Therese Fagerqvist
- Department of Public Health/Geriatrics, Rudbeck Laboratory, Uppsala University, 751 85Uppsala, Sweden
-
- Joakim Bergström
- Department of Public Health/Geriatrics, Rudbeck Laboratory, Uppsala University, 751 85Uppsala, Sweden
-
- Eva Nordström
- BioArctic Neuroscience AB, Stockholm, Sweden
-
- Christer Möller
- BioArctic Neuroscience AB, Stockholm, Sweden
-
- Lars Lannfelt
- Department of Public Health/Geriatrics, Rudbeck Laboratory, Uppsala University, 751 85Uppsala, Sweden
-
- Martin Ingelsson
- Department of Public Health/Geriatrics, Rudbeck Laboratory, Uppsala University, 751 85 Uppsala, Sweden. Tel.: Fax:
収録刊行物
-
- Immunotherapy
-
Immunotherapy 6 (2), 141-153, 2014-02
Informa UK Limited
